Edwards’ Pascal Improves Mitral Regurgitation In Early Trial Results

One-month results from the CLASP trial, presented at the German Cardiology Meeting (DGK), show Edwards’ Pascal mitral valve repair device reduces mitral regurgitation in heart failure patients with moderate to severe mitral regurgitation.

PASCAL Animated Side And Top
Edwards' Pascal Mitral Valve Repair Device • Source: Edwards Lifesciences

More from R&D

More from Business